The Impact of Asthma on the Quality of Life and Symptoms in Patients with Chronic Rhinosinusitis by Ana Penezić et al.




The Impact of Asthma on the Quality of Life and Symptoms in Patients with 
Chronic Rhinosinusitis 
 
Ana Penezić1, Matej Paić2, Tomislav Gregurić3, Marko Velimir Grgić1, Tomislav Baudoin1, 
Livije Kalogjera1 
 
1Clinical Department of Otolaryngology and Head and Neck Surgery, University Hospital Centre 
“Sestre Milosrdnice”, Vinogradska 29, 10000 Zagreb, Croatia, 2Department of Gastroenterology, 
University Hospital „Sveti Duh“, Sv.Duh 64, 10000 Zagreb, Croatia, 3Department of Radiology, 




Objective: The aim of the study was to test whether asthma per se is a factor influencing subjective 
and objective outcomes in patients with chronic rhinosinusitis (CRS).  
Materials and methods: This was a cross-sectional study which enrolled CRS patients for 2 years. 
Patients were asked to score the severity of their rhinosinusitis symptoms on a visual analog scale (VAS), 
and to fill out a questionnaire on the health-related quality of life– Sinonasal Outcome Test 22 (SNOT-22). 
CRS was confirmed by symptoms, endoscopy and CT findings. We have defined matching pairs of asthmatic 
and non-asthmatic patients based on nasal polyp presence, gender, age and allergic sensitization and 
analysed the difference in symptom scores, HRQL impairment and imaging scores.  
Results: We observed pairs from 250 patients with CRS, from which 65 (26%) had asthma and 185 
(74%) did not have asthma. There was a higher proportion of CRS with nasal polyps (64.2% vs. 29.7%) in 
the asthma group and positive history of allergy (67.2% vs. 28.2%). Lund-Mackay (LM) scores were higher 
in asthma patients (13.06 vs. 8.83). We found 60 matching asthma and non-asthma CRS pairs. There was no 
difference in the SNOT-22 total score (46.45 for asthma and 43.52 for non-asthma group, p<0.357). When 
comparing each symptom individually in matching patients, we found a statistically significant difference in 
taste and smell (p<0.016), and there were slightly higher scores in falling asleep and morning tiredness 
(p<0.053 and p<0.069). There were more allergy positive patients in the asthma group (66.1% asthma group 
vs. 50.8% non-asthma group) when we stratified for CRS phenotypes, gender and age. Asthma patients had 
worse VAS scores for smell than matching couples in the non-asthma group (p<0.013). The LM score was 
significantly higher in male patients both in the asthmatic and non-asthmatic group (p=0.039 and 0.015), 
while SNOT-22 was insignificantly worse in female asthmatics (p=0.079). Global Osteitis scores were 
higher in the CRS with nasal polyposis and asthma subgroup of patients.  
Conclusion: CRS patients with asthma have significantly impaired smell and taste. Aspirin 
intolerant, asthma positive CRS with nasal polyposis patients have significantly higher osteitis score when 
compared to other subgroups of CRS patients.  
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